Deubiquitylating enzymes as cancer stem cell therapeutics.

Haq, Saba; Suresh, Bharathi; Ramakrishna, Suresh

Haq, Saba; Suresh, Bharathi; Ramakrishna, Suresh.

Afiliação

Haq S; Department of Lifesciences, College of Natural Sciences, Hanyang University, Seoul, South Korea.
Suresh B; Department of Pharmacology and Brain Korea 21 PLUS Project for Medical Science, Yonsei University College of Medicine, Seoul, South Korea. Electronic address: bharathi.suri@yuhs.ac.
Ramakrishna S; Graduate School of Biomedical Science and Engineering, Hanyang University, Seoul, South Korea; College of Medicine, Hanyang University, Seoul, South Korea. Electronic address: suri28@hanyang.ac.kr.

Biochim Biophys Acta Rev Cancer ; 1869(1): 1-10, 2018 Jan.

Article em En | MEDLINE | ID: mdl-29054474

Assuntos

Antineoplásicos/uso terapêutico; Enzimas Desubiquitinantes/fisiologia; Enzimas Desubiquitinantes/uso terapêutico; Neoplasias/terapia; Células-Tronco Neoplásicas/efeitos dos fármacos; Animais; Diferenciação Celular/efeitos dos fármacos; Humanos; Neoplasias/patologia; Células-Tronco Neoplásicas/patologia; Ubiquitinação/fisiologia

Palavras-chave

Cancer stem cells; Cellular reprogramming; DUB inhibitors; Direct conversion; Protein induced pluripotent stem cells; Yamanaka factors

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Células-Tronco Neoplásicas / Enzimas Desubiquitinantes / Neoplasias / Antineoplásicos Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google